Characterization of Streptococcus pneumoniae detected in clinical respiratory tract samples in southern Sweden 2 to 4 years after introduction of PCV13
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To determine the serotype distribution and antimicrobial resistance of Streptococcus
pneumoniae associated with mucosal infections in patients of all ages, 2 to 4 years
after the transition from a 10-valent pneumococcal conjugate vaccine (PCV10) to PCV13
in the childhood immunization programme.